AGO2 and cardiac hypertrophy: Several studies have demonstrated the involvement of circRNAs in the pathogenesis of myocardial hypertrophy, via sponging miRNAs 23-25; however, an RNA pull-down assay in this study revealed that CHACR did not bind to AGO-2, as an indicator protein for circRNAs to function as sponges.